PRIMECAP MANAGEMENT CO/CA/ - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 103 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRIMECAP MANAGEMENT CO/CA/ ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$189,530,626
+38.5%
8,267,421
-0.4%
0.16%
+40.4%
Q2 2023$136,855,737
+0.8%
8,299,317
+9.1%
0.11%
-3.4%
Q1 2023$135,714,428
-32.6%
7,607,311
+10.1%
0.12%
-35.9%
Q4 2022$201,252,455
+16.9%
6,911,142
-1.6%
0.18%
+10.2%
Q3 2022$172,159,000
+551.8%
7,026,892
+10.4%
0.17%
+595.8%
Q2 2022$26,411,000
-63.6%
6,364,094
+1.1%
0.02%
-56.4%
Q1 2022$72,484,000
+16.1%
6,291,991
+0.6%
0.06%
+27.9%
Q4 2021$62,445,000
-22.6%
6,256,991
+1.2%
0.04%
-24.6%
Q3 2021$80,725,000
-33.0%
6,181,091
+0.4%
0.06%
-29.6%
Q2 2021$120,489,000
-5.7%
6,153,691
+2.5%
0.08%
-9.0%
Q1 2021$127,739,000
-1.1%
6,005,593
+38.3%
0.09%
-7.3%
Q4 2020$129,102,000
+66.7%
4,342,491
+21.5%
0.10%
+50.0%
Q3 2020$77,464,000
-2.0%
3,574,691
+0.8%
0.06%
-5.9%
Q2 2020$79,049,000
+46.6%
3,544,791
+0.1%
0.07%
+28.3%
Q1 2020$53,918,000
+12.2%
3,542,591
+69.2%
0.05%
+51.4%
Q4 2019$48,071,000
+801.6%
2,093,691
+747.7%
0.04%
+775.0%
Q3 2019$5,332,000246,9770.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 810,000$19,845,0008.20%
NEA Management Company, LLC 4,912,306$108,316,0005.41%
Frazier Life Sciences Management, L.P. 1,894,000$46,403,0003.57%
RA Capital Management 5,471,067$134,041,0002.86%
Samsara BioCapital, LLC 345,293$8,460,0001.97%
Altium Capital Management LP 170,000$4,165,0001.53%
Parkman Healthcare Partners LLC 187,989$4,606,0001.31%
Rock Springs Capital Management LP 1,760,865$43,141,0001.11%
EAM Investors, LLC 198,699$4,868,0001.06%
Prosight Management, LP 80,000$1,960,0001.05%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders